Spheryx awarded Ph II grant to modify tech for biologics industry
Spheryx, Inc. has been awarded a $1.5m grant over two years to support modifications to the company’s propriety protein aggregation detection and monitoring technology.
Archives for July 6, 2017
Pharma finance
It's a seller's market as buyers narrow therapeutic focus, says inVentiv
Biopharmaceutical dealmakers are narrowing in on therapeutic areas as company’s look to lead specific markets or gain a technical advantage.
INC Research expands catalyst program to psychiatric-related trials
The new network provides member sites with access to dedicated support as psychiatry clinical research becomes more complex, says CRO.